ASND has been in the news 326% more than usual
Sep 17, 2024, 2:31 PM
-6.29%
What does ASND do
Ascendis Pharma A/S is a global biopharmaceutical company developing drug candidates for growth hormone deficiency, endocrinology, CNS disorders, infectious diseases, and diabetes. It operates through multiple subsidiaries in Germany and Denmark.
ASND has been in the news recently: Advanced Energy Industries, with a market cap of $3.72 billion, expects 41.5% annual earnings growth despite a 12.2% decline in sales. Meanwhile, Ascendis Pharma's TransCon CNP has demonstrated superior growth in trials, potentially impacting BioMarin's Voxzogo as it aims for $4 billion in revenue by 2027.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.